Jane Street’s Trillium Therapeutics Inc. TRIL Stock Holding History

Jane Street’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-173,761	Closed	-$3.05M	–	11230
2021 Q3	$3.05M	Buy	173,761 +162,463	+1,438%	+$1.9M	﹤0.01%	3619
2021 Q2	$109K	Sell	11,298 -24,245	-68%	-$228K	﹤0.01%	9221
2021 Q1	$381K	Buy	35,543 +21,724	+157%	+$269K	﹤0.01%	7306
2020 Q4	$204K	Sell	13,819 -58,368	-81%	-$842K	﹤0.01%	6930
2020 Q3	$1.02M	Buy	+72,187	New	+$720K	﹤0.01%	4062
2020 Q2	–	Sell	-31,505	Closed	-$195K	–	7750
2020 Q1	$124K	Buy	31,505 +2,917	+10%	+$11K	﹤0.01%	4862
2019 Q4	$29K	Buy	+28,588	New	+$10.9K	﹤0.01%	4941
2019 Q2	–	Sell	-22,494	Closed	-$14K	–	6003
2019 Q1	$14K	Sell	22,494 -2,168	-9%	-$2.65K	﹤0.01%	4913
2018 Q4	$43K	Buy	+24,662	New	+$74K	﹤0.01%	4737
2017 Q1	–	Sell	-19,230	Closed	-$109K	–	4869
2016 Q4	$109K	Buy	+19,230	New	+$191K	﹤0.01%	3858

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Jane Street's TRIL Position: Q4 2021 in Review

Jane Street sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 173,761 shares — an estimated $3.05M sold.

Jane Street first reported a position in TRIL in Q4 2016 and held it in 10 quarters. The position peaked at $3.05M in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

Jane Street reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
Jane Street sold 173,761 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $3.05M.
Jane Street first reported a position in Trillium Therapeutics Inc. in Q4 2016 and held it in 10 quarters.
Jane Street's Trillium Therapeutics Inc. position peaked at $3.05M in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Jane Street's 13F filing for Q4 2021, filed 15 Feb 2022.